Ear Infection Treatment Market Value Projected To Reach US$ 9.6 Billion By 2028 Covering Covid-19 Impact: Acumen Research and Consulting
05 août 2021 11h10 HE
|
Acumen Research and Consulting
Acumen Research and Consulting, a global provider of market research studies, in a recently published report titled “Ear Infection Treatment Market– Global Industry Analysis, Market Size,...
Otonomy to Report Second Quarter 2019 Financial Results and Provide Corporate Update
25 juil. 2019 16h05 HE
|
Otonomy, Inc.
SAN DIEGO, July 25, 2019 (GLOBE NEWSWIRE) -- Otonomy, Inc. (NASDAQ: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, today announced it...
Otonomy to Present at the Raymond James Life Sciences and MedTech Conference
12 juin 2019 08h00 HE
|
Otonomy, Inc.
SAN DIEGO, June 12, 2019 (GLOBE NEWSWIRE) -- Otonomy, Inc. (NASDAQ: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, today announced that...
Otonomy to Report Second Quarter 2018 Financial Results and Provide Corporate Update
01 août 2018 16h05 HE
|
Otonomy, Inc.
SAN DIEGO, Aug. 01, 2018 (GLOBE NEWSWIRE) -- Otonomy, Inc. (NASDAQ: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for otology, today announced it will...
Otonomy Successfully Completes Open-Label Clinical Trial for OTIPRIO® in Patients with History of Otitis Media Requiring Tympanostomy Tubes
15 sept. 2016 07h30 HE
|
Otonomy, Inc.
SAN DIEGO, Sept. 15, 2016 (GLOBE NEWSWIRE) -- Otonomy, Inc. (Nasdaq:OTIC), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics for diseases...
ENT Devices Market size to exceed $24 Billion by 2023: Global Market Insights, Inc.
21 juin 2016 08h30 HE
|
Global Market Insights
Delaware, June 21, 2016 (GLOBE NEWSWIRE) -- ENT Devices Market size is estimated to exceed USD 24 billion by 2023; according to the latest research report from Global Market Insights, Inc....
Otonomy Announces Pricing of Public Offering of Common Stock
06 janv. 2016 19h39 HE
|
Otonomy, Inc.
SAN DIEGO, Jan. 06, 2016 (GLOBE NEWSWIRE) -- Otonomy, Inc. (NASDAQ:OTIC), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics for diseases...
Studsvik AB (publ): Interim Report, January-June 2002
19 août 2002 07h18 HE
|
Studsvik
STOCKHOLM, Sweden, Aug. 19, 2002 (PRIMEZONE) -- Studsvik AB (publ):
- Studsvik's net sales increased by 21 per cent to SEK 492.7
million (408.5).
- The result before tax improved considerably...
Interim Report on the Operations of AB Custos for the Period January 1 - June 30, 2002
17 juil. 2002 04h55 HE
|
Custos
STOCKHOLM, Sweden, July 17, 2002 (PRIMEZONE) -- AB Custos:
. Total return on Custos shares during the report period was 14
percent, more than 35 percentage points better than the SIX
Return...
Kungsleden AB (publ): Interim Report, January 1- March 31, 2002 (with link)
23 avr. 2002 06h42 HE
|
Kungsleden
STOCKHOLM, Sweden, April 23, 2002 (PRIMEZONE) -- Kungsleden AB (publ):
-- Profit before tax was SEK 129 m (74 m), corresponding to
earnings per share of SEK 6.8 (3.9).
-- Kungsleden's...